Subclinical and Device Detected Atrial Fibrillation Pondering the Knowledge Gap
Published: November 07, 2019
- Subclinical AF (SCAF) is associated with at least a two-fold increased risk of stroke and almost six-fold increased risk of progressing to clinical AF.
- SCAF is asymptomatic and is now detected by a variety of monitoring devices, including implantable and wearables devices.
- This statement explores the evidence regarding SCAF prevalence, clinical significance and management of SCAF when detected by implantable and wearable cardiac devices.
- 2019 Focused Update of the 2014 Guideline for the Management of Patients with Atrial Fibrillation
- 2014 Guideline for the Management of Patients with Atrial Fibrillation
- 2016 Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter
- Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity